Cliniphar Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Net Income	146	-	-
Depreciation & Amortization	32	-	-
Loss (Gain) From Sale of Assets	3	-	-
Loss (Gain) From Sale of Investments	4	-	-
Other Operating Activities	-14	-	-
Change in Accounts Receivable	7	-	-
Change in Accounts Payable	2	-	-
Change in Other Net Operating Assets	99	-	-
Operating Cash Flow	279	-	-
Capital Expenditures	-10	-	-
Investment in Securities	419	-	-
Other Investing Activities	-11	-	-
Investing Cash Flow	398	-	-
Long-Term Debt Repaid	-379	-	-
Net Debt Issued (Repaid)	-379	-	-
Other Financing Activities	-2	-	-
Financing Cash Flow	-381	-	-
Foreign Exchange Rate Adjustments	2	-	-
Miscellaneous Cash Flow Adjustments	-1	-	-
Net Cash Flow	297	-	-
Free Cash Flow	269	-	-
Free Cash Flow Margin	7.27%	-	-
Free Cash Flow Per Share	269.00	-	-
Cash Interest Paid	8	-	-
Cash Income Tax Paid	13	-	-
Levered Free Cash Flow	195.75	-	-
Unlevered Free Cash Flow	200.75	-	-
Change in Working Capital	108	-	-